[Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000769:Anesthesia, Inhalation; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001285:Atropine / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004195:Disease Models, Animal; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D005019:Ethyl Ethers; D006221:Halothane; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy; D011189:Potassium Chloride / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D005019:Ethyl Ethers; D010276:Parasympatholytics; D013565:Sympatholytics; D014665:Vasodilator Agents; D011189:Potassium Chloride; D001285:Atropine; D011802:Quinidine; D006221:Halothane; D010646:Phentolamine
Kombinirovannoe deĭstvie beta-adrenoblokatorov s drugimi farmakologicheskimi sredstvami (obzor literautry.